scispace - formally typeset
N

Nora D. Volkow

Researcher at National Institute on Drug Abuse

Publications -  1038
Citations -  121498

Nora D. Volkow is an academic researcher from National Institute on Drug Abuse. The author has contributed to research in topics: Dopamine & Addiction. The author has an hindex of 165, co-authored 958 publications receiving 107463 citations. Previous affiliations of Nora D. Volkow include National Institutes of Health & North Shore University Hospital.

Papers
More filters
Journal Article

Reproducibility of 11C-Raclopride Binding in the Rat Brain Measured with the MicroPET R4: Effects of Scatter Correction and Tracer Specific Activity

David Alexoff, +9 more
- 01 May 2003 - 
TL;DR: This study shows that the (11)C-raclopride microPET-derived DVR is reproducible and suitable for studying D2R availability in the rat brain and the effects of tracer-specific activity and photon scatter correction on measures of D2 receptor (D2R) availability.
Journal Article

Intersubject Variability of Brain Glucose Metabolic Measurements in Young Normal Males

Gene-Jack Wang, +4 more
- 01 Sep 1994 - 
TL;DR: Significant intersubject variability for regional brain metabolic values in normal controls is shown and age-related decreases in frontal metabolism that occur even in relatively young adults are documents.
Journal ArticleDOI

Stigma and the Toll of Addiction

Nora D. Volkow
- 01 Apr 2020 - 
TL;DR: Stigma and the Toll of Addiction Among the challenges in delivering appropriate care to the millions of people in the United States with substance use disorder is the chilling effect of stigma.
Journal ArticleDOI

Regional Brain Metabolic Response to Lorazepam in Subjects at Risk for Alcoholism

Nora D. Volkow, +11 more
- 01 Apr 1995 - 
TL;DR: The decreased Cerebellar baseline metabolism in FP as well as the blunted cerebellar response to lorazepam challenge may reflect disrupted activity of benzodiazepine-GABA receptors in cerebellum, which could account for the decreased sensitivity to the motor effects of alcohol and benzodiazines in FP subjects.
Journal ArticleDOI

Whole-body pharmacokinetics of HDAC inhibitor drugs, butyric acid, valproic acid and 4-phenylbutyric acid measured with carbon-11 labeled analogs by PET.

Sung Won Kim, +11 more
- 01 Oct 2013 - 
TL;DR: The unique biodistribution of each of these drugs may be of relevance in understanding their therapeutic and side effect profile including their teratogenic effects.